The Real Good Food Company Reports Third Quarter 2021 Financial Results
The Real Good Food Company (Nasdaq: RGF) reported a 136% year-over-year increase in net sales for Q3 2021, reaching $23.0 million. Gross margin rose significantly, with adjusted gross margin at 17.1%. Following its IPO, the company achieved a pro forma cash balance of $44 million and expanded its credit facility capacity to $70 million. For 2021, net sales are projected at $83 million to $85 million, while 2022 forecasts net sales of $115 million to $125 million. Despite losses in adjusted EBITDA, growth metrics signal strong market performance.
- Net sales increased 136% to $23.0 million in Q3 2021.
- Gross margin increased by 1,190 basis points to 10.2%.
- Pro forma cash balance of $44 million post-IPO.
- Credit facility capacity expanded from $18.5 million to $50 million.
- Adjusted EBITDA loss increased to $3.0 million, compared to a $1.3 million loss in Q3 2020.
- Net loss rose to $11.8 million, a significant increase from $4.2 million in the prior year.
Record Net Sales of
Pro Forma Cash Balance of
Company Provides Full Year 2021 and 2022 Outlook and Provides Long-Term Targets
CHERRY HILL, N.J., Dec. 07, 2021 (GLOBE NEWSWIRE) -- The Real Good Food Company, Inc. (Nasdaq: RGF) (“Real Good Foods” or the “Company”), a health- and wellness-focused frozen food company, today reported financial results for its third quarter ended September 30, 2021.
Third Quarter 2021 Highlights
- Net sales increased
136% to$23.0 million - Gross margin increased 1,190 basis points to
10.2% - Adjusted gross margin(1) increased 410 basis points to
17.1%
(All comparisons above are to the third quarter of 2020.)
“We are pleased with our successful IPO during the month of November and our strong third quarter results,” said Bryan Freeman, Executive Chairman. “These results demonstrate the strength of the Real Good Foods brand and consumers’ desire for high protein, lower carbohydrate foods. We are in the early stages of penetrating our total addressable market opportunity and are more aggressively working to achieve gross margins in line with our peers.”
Successful Initial Public Offering
Subsequent to the third quarter end, on November 9, 2021, the Company closed its initial public offering (“IPO”) in which it offered 5,333,333 shares of its Class A common stock at a price to the public of
Financial Results for the Quarter Ended September 30, 2021
Net sales increased
Gross profit increased
Adjusted gross profit(1) increased
Total operating expenses increased by
Adjusted EBITDA(1) was a loss of
Loss from operations increased by
Net loss increased by
Balance Sheet Highlights
As of September 30, 2021, the Company had cash and cash equivalents of
Pro forma cash balance and pro forma debt balance give effect to the net proceeds received from the IPO, the conversion of the convertible notes, the pay down of outstanding debt, pay down of certain contingent liabilities, as well as cash borrowings under a newly amended credit facility, as described below. After considering the effects of the foregoing, the Company’s September 30, 2021 pro forma cash balance was
Amounts in millions: | |||
Actual Cash at September 30, 2021 | $ | 1.7 | |
Net Proceeds Received from IPO | 59.5 | ||
Pay down of Debt | (10.2 | ) | |
Transaction Expenses | (4.0 | ) | |
Contingent Payments | (3.0 | ) | |
Pro Forma Cash at September 30, 2021 | $ | 44.0 |
After the quarter end, the Company amended its existing revolving credit facility to, among other things: 1) increase the maximum borrowing capacity under the revolving credit facility from
The Company believes that this pro forma cash balance, along with the increase in borrowing capacity, provide it with sufficient liquidity to fund the business for the foreseeable future.
Outlook
For the year ending December 31, 2021, the Company currently expects:
- Net sales of approximately
$83 million to$85 million , reflecting an increase of approximately113% to118% compared to 2020 - Adjusted gross margin of approximately
19.6% to21.0% - Adjusted EBITDA loss of approximately
$8.0 million to$9.5 million
For the year ending December 31, 2022, the Company currently expects:
- Net sales of approximately
$115 million to$125 million , reflecting an increase of approximately37% to49% compared to 2021 - Adjusted gross margin to increase on a year-over-year basis
- Adjusted EBITDA loss of approximately
$8 million to$15 million
Long-term, the Company currently expects:
- Net sales growth of at least
30% - Adjusted gross margin of at least
30%
The Company is not providing guidance for gross margin or net loss, the most directly comparable GAAP measures, and similarly cannot provide a reconciliation between its forecasted adjusted gross margin and gross margin and adjusted EBITDA and net loss without unreasonable effort due to the unavailability of reliable estimates for certain items. These items are not within the Company’s control and may vary greatly between periods and could significantly impact future financial results.
(1) Adjusted gross profit, adjusted gross margin, and adjusted EBITDA are non-GAAP financial measures. Adjusted gross profit means, for any reporting period, gross profit adjusted to exclude the impacts of costs and adjustments identified by management as affecting the comparability of our gross profit from period to period. Adjusted gross margin means adjusted gross profit as a percentage of net sales. Adjusted EBITDA means, for any reporting period, net income (loss) before depreciation and amortization, income taxes, and interest expense, adjusted to exclude the impact of transaction expenses, as well as other costs and adjustments identified by management as affecting the comparability of our operating results from period to period. See the information provided under the section entitled “Non-GAAP Financial Measures” within this release for a discussion of why we believe these measures are important, and the reconciliation table at the end of this release for a reconciliation thereof to the most directly comparable GAAP measures.
Conference Call and Webcast Details
The Company will host a conference call with members of the executive management team to discuss these results with additional comments and details today at 4:30 p.m. ET. The conference call webcast and supplemental presentation will be available on the “Investors” section of the Company’s website at www.realgoodfoods.com. To participate on the live call, listeners in the U.S. may dial (877) 451-6152 and international listeners may dial (201) 389-0879. A telephone replay will be available approximately two hours after the call concludes through December 21, 2021, and can be accessed by dialing (844) 512-2921 from the United States, or (412) 317-6671 internationally, and entering the passcode 13725258.
About The Real Good Food Company
Founded in 2016, Real Good Foods believes there is a better way to enjoy our favorite foods. Its brand commitment, “Real Food You Feel Good About Eating,” represents the Company’s strong belief that, by eating its food, consumers can enjoy more of their favorite foods and, by doing so, live better lives as part of a healthier lifestyle. Its mission is to make craveable, nutritious comfort foods that are low in carbohydrates, high in protein, and made from gluten- and grain-free real ingredients more accessible to everyone, improve human health, and, in turn, improve the lives of millions of people. Real Good Foods offers delicious options across breakfast, lunch, dinner, and snacking occasions available in over 16,000 stores nationwide, including Walmart, Costco, Kroger, and Target, and directly from its website at www.realgoodfoods.com. Learn more about Real Good Foods by visiting its website or on Instagram at @realgoodfoods, where it has one of the largest social media followings of any brand within the frozen food industry today with nearly 400,000 followers.
Non-GAAP Financial Measures
In addition to our financial results determined in accordance with generally accepted accounting principles in the United States (“GAAP”), we believe that adjusted gross profit, adjusted gross margin, and adjusted EBITDA, each of which is a non-GAAP financial measure, are useful performance measures and metrics for investors to evaluate current trends in our operations and compare the ongoing financial and operating performance of our business from period to period. In addition, management uses these non-GAAP financial measures to assess our operating performance and for internal planning purposes. We also believe these measures are widely used by investors, securities analysts, and other parties in evaluating companies in our industry as measures of financial and operational performance. However, the non-GAAP financial measures included in this press release have limitations and should not be considered in isolation, as substitutes for, or as superior to, performance measures calculated in accordance with GAAP. Other companies may calculate these measures differently, or may not calculate them at all, which limits the usefulness of these measures as comparative measures. Because of these limitations, we consider, and you should consider, adjusted gross profit, adjusted gross margin, and adjusted EBITDA with other operating and financial performance measures presented in accordance with GAAP. To the extent the Company utilizes such non-GAAP financial measures in the future, it expects to calculate them using a consistent method from period to period.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which statements are subject to considerable risks and uncertainties. Forward-looking statements include all statements other than statements of historical fact contained in this press release, including statements regarding our projected financial results, including net sales, gross margin, gross profit, adjusted gross profit, adjusted gross margin, and adjusted EBITDA. We have attempted to identify forward-looking statements by using words such as "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "should," "will," or "would," and similar expressions or the negative of these expressions.
Forward-looking statements represent our management's current expectations and predictions about trends affecting our business and industry and are based on information available as of the time such statements are made. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy or completeness. Forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements predicted, assumed or implied by the forward-looking statements. Some of the risks and uncertainties that may cause our actual results to materially differ from those expressed or implied by these forward-looking statements are described in the section entitled "Risk Factors" in our Form S-1, as amended, filed in connection with our IPO.
In addition, readers are cautioned that we may make future changes to our business and operations in response to the challenges and impacts of the COVID-19 pandemic, or in response to other business developments, which changes may be inconsistent with our prior forward-looking statements, and which may not be disclosed in future public announcements.
Condensed Statements of Operations
(In thousands)
THREE MONTHS ENDED | NINE MONTHS ENDED | ||||||||||||||
SEPTEMBER 30, | SEPTEMBER 30, | ||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||
Net sales | $ | 23,014 | $ | 9,745 | $ | 58,477 | $ | 27,799 | |||||||
Cost of sales | 20,659 | 9,907 | 49,447 | 26,346 | |||||||||||
Gross profit | 2,355 | (162 | ) | 9,030 | 1,453 | ||||||||||
Operating expenses: | |||||||||||||||
Selling and distribution | 4,323 | 1,754 | 10,291 | 5,703 | |||||||||||
Marketing | 1,732 | 356 | 3,119 | 1,936 | |||||||||||
Administrative | 1,875 | 682 | 7,677 | 1,755 | |||||||||||
Total operating expenses | 7,930 | 2,792 | 21,087 | 9,394 | |||||||||||
Loss from operations | (5,575 | ) | (2,954 | ) | (12,057 | ) | (7,941 | ) | |||||||
Interest expense | 839 | 1,262 | 4,322 | 3,744 | |||||||||||
Other income | (309 | ) | - | (309 | ) | - | |||||||||
Change in fair value of convertible debt | 5,730 | - | 6,100 | - | |||||||||||
Loss before income taxes | (11,835 | ) | (4,216 | ) | (22,170 | ) | (11,685 | ) | |||||||
Income tax expense | - | - | - | 13 | |||||||||||
Net Loss | $ | (11,835 | ) | $ | (4,216 | ) | $ | (22,170 | ) | $ | (11,698 | ) | |||
Preferred return on Series A preferred units | 146 | 136 | 438 | 409 | |||||||||||
Net loss attributable to common unitholders | $ | (11,981 | ) | $ | (4,352 | ) | $ | (22,608 | ) | $ | (12,107 | ) | |||
Net loss per common unit (basic and diluted) | (190.3 | ) | (70.1 | ) | (359.1 | ) | (195.0 | ) | |||||||
Weighted-average common units outstanding (basic and diluted)* | 62,957 | 62,097 | 62,957 | 62,097 |
* The computations of earnings per unit and weighted-average units outstanding do not consider the effects of the Company’s IPO, as discussed earlier in this press release.
Non-GAAP Financial Measures - Reconciliation
THREE MONTHS ENDED | NINE MONTHS ENDED | ||||||||||||||
SEPTEMBER 30, | SEPTEMBER 30, | ||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||
Gross Profit | $ | 2,355 | $ | (162 | ) | $ | 9,030 | $ | 1,453 | ||||||
Cost related to financial hardship of co-manufacturer (1) | - | 967 | - | 967 | |||||||||||
Inventory write-downs (2) | - | 465 | - | 465 | |||||||||||
Start-up and idle capacity costs (3) | 904 | - | 2,398 | - | |||||||||||
Costs related to the COVID-19 pandemic (4) | 682 | - | 1,175 | 308 | |||||||||||
Adjusted Gross Profit | $ | 3,941 | $ | 1,270 | $ | 12,603 | $ | 3,193 | |||||||
Adjusted Gross Margin | 17.1 | % | 13.0 | % | 21.6 | % | 11.5 | % |
(1) Represents costs recognized as a result of a co-manufacturer’s financial hardship. These costs include the non-recurring write down of unrecoverable raw materials inventory.
(2) Represents a non-recurring write-down of obsolete inventory related to a change in strategy for certain products and customers. The amount of the write-down reflects only that portion of obsolete inventory that management estimates to be above normalized levels.
(3) Represents start-up costs associated with commencing operations at our City of Industry Facility and other costs associated with temporary manufacturing capacity at our City of Industry Facility, including indirect labor costs, utility costs, and rent.
(4) Represents direct costs incurred in connection with the COVID-19 pandemic, including freight rush charges, labor costs, tolling upcharges, and storage.
THREE MONTHS ENDED | NINE MONTHS ENDED | ||||||||||||||
SEPTEMBER 30, | SEPTEMBER 30, | ||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||
Net Loss | $ | (11,835 | ) | $ | (4,216 | ) | $ | (22,170 | ) | $ | (11,698 | ) | |||
Depreciation and amortization | 344 | 153 | 791 | 449 | |||||||||||
Provision for income tax | - | - | - | 13 | |||||||||||
Interest expense | 839 | 1,262 | 4,322 | 3,744 | |||||||||||
Other Income | (309 | ) | - | (309 | ) | - | |||||||||
Change in fair value of convertible debt (1) | 5,730 | - | 6,100 | - | |||||||||||
Cost related to financial hardship of co-manufacturer (2) | - | 967 | - | 967 | |||||||||||
Inventory write-down (3) | - | 465 | - | 465 | |||||||||||
Start-up and idle capacity costs (4) | 904 | - | 2,398 | - | |||||||||||
Costs related to the COVID-19 pandemic (5) | 682 | - | 1,175 | 308 | |||||||||||
Share-based compensation (6) | - | - | - | - | |||||||||||
Transaction expenses (7) | 652 | 99 | 3,353 | 277 | |||||||||||
Adjusted EBITDA | $ | (2,993 | ) | $ | (1,270 | ) | $ | (4,340 | ) | $ | (5,475 | ) |
(1) For the periods prior to the three months ending September 30, 2021, amounts related to the changes in fair value of convertible debt were excluded due to those amounts being de minimis for those periods.
(2) Represents costs recognized as a result of a co-manufacturer’s financial hardship. These costs include the non-recurring write down of unrecoverable raw materials inventory.
(3) Represents a non-recurring write-down of obsolete inventory related to a change in strategy for certain products and customers. The amount of the write-down reflects only that portion of obsolete inventory that management estimates to be above normalized levels.
(4) Represents start-up costs associated with commencing operations at our City of Industry Facility and other costs associated with temporary manufacturing capacity at our City of Industry Facility, including indirect labor costs, utility costs, and rent.
(5) Represents direct costs incurred in connection with the COVID-19 pandemic, including freight rush charges, labor costs, tolling upcharges, and storage.
(6) Represents equity-based compensation expense.
(7) Represents costs incurred in connection with pursuing certain strategic and financing transactions, including legal, consulting, and accounting costs.
RECONCILIATION OF CERTAIN REPORTED ITEMS TO CERTAIN NON-GAAP ADJUSTED ITEMS
NINE MONTHS ENDED | ||||||||||||||||||||
SEPTEMBER 30, | ||||||||||||||||||||
2021 | ||||||||||||||||||||
Net Sales | Gross Profit | Gross Margin | Administrative Expenses | Income from Operations | Operating Margin | |||||||||||||||
Reported | $ | 58,477 | $ | 9,030 | 15.4 | % | $ | 7,677 | $ | (12,057 | ) | (20.6 | )% | |||||||
Items Affecting Comparability: | ||||||||||||||||||||
Cost related to financial hardship of co-manufacturer (1) | - | - | - | - | ||||||||||||||||
Inventory write-downs (2) | - | - | - | - | ||||||||||||||||
Start-up and idle capacity costs (3) | - | 2,398 | - | 2,398 | ||||||||||||||||
Costs related to the COVID-19 pandemic (4) | - | 1,175 | - | 1,175 | ||||||||||||||||
Share-based compensation (5) | - | - | - | - | ||||||||||||||||
Transaction expenses (6) | - | - | (3,353 | ) | 3,353 | |||||||||||||||
Adjusted | $ | 58,477 | $ | 12,603 | 21.6 | % | $ | 4,324 | $ | (5,131 | ) | (8.8 | )% | |||||||
NINE MONTHS ENDED | ||||||||||||||||||||
SEPTEMBER 30, | ||||||||||||||||||||
2020 | ||||||||||||||||||||
Net Sales | Gross Profit | Gross Margin | Administrative Expenses | Income from Operations | Operating Margin | |||||||||||||||
Reported | $ | 27,799 | $ | 1,453 | 5.2 | % | $ | 1,755 | $ | (7,941 | ) | (28.6 | )% | |||||||
Items Affecting Comparability: | ||||||||||||||||||||
Cost related to financial hardship of co-manufacturer (1) | - | 967 | - | 967 | ||||||||||||||||
Inventory write-downs (2) | - | 465 | - | 465 | ||||||||||||||||
Start-up and idle capacity costs (3) | - | - | - | - | ||||||||||||||||
Costs related to the COVID-19 pandemic (4) | - | 308 | - | 308 | ||||||||||||||||
Share-based compensation (5) | - | - | - | - | ||||||||||||||||
Transaction expenses (6) | - | - | (277 | ) | 277 | |||||||||||||||
Adjusted | $ | 27,799 | $ | 3,193 | 11.5 | % | $ | 1,478 | $ | (5,924 | ) | (21.3 | )% | |||||||
THREE MONTHS ENDED | ||||||||||||||||||||
SEPTEMBER 30, | ||||||||||||||||||||
2021 | ||||||||||||||||||||
Net Sales | Gross Profit | Gross Margin | Administrative Expenses | Income from Operations | Operating Margin | |||||||||||||||
Reported | $ | 23,014 | $ | 2,355 | 10.2 | % | $ | 1,875 | $ | (5,575 | ) | (24.2 | )% | |||||||
Items Affecting Comparability: | ||||||||||||||||||||
Cost related to financial hardship of co-manufacturer (1) | - | - | - | - | ||||||||||||||||
Inventory write-downs (2) | - | - | - | - | ||||||||||||||||
Start-up and idle capacity costs (3) | - | 904 | - | 904 | ||||||||||||||||
Costs related to the COVID-19 pandemic (4) | - | 682 | - | 682 | ||||||||||||||||
Share-based compensation (5) | - | - | - | - | ||||||||||||||||
Transaction expenses (6) | - | - | (652 | ) | 652 | |||||||||||||||
Adjusted | $ | 23,014 | $ | 3,941 | 17.1 | % | $ | 1,223 | $ | (3,337 | ) | (14.5 | )% | |||||||
THREE MONTHS ENDED | ||||||||||||||||||||
SEPTEMBER 30, | ||||||||||||||||||||
2020 | ||||||||||||||||||||
Net Sales | Gross Profit | Gross Margin | Administrative Expenses | Income from Operations | Operating Margin | |||||||||||||||
Reported | $ | 9,745 | $ | (162 | ) | (1.7 | )% | $ | 682 | $ | (2,954 | ) | (30.3 | )% | ||||||
Items Affecting Comparability: | ||||||||||||||||||||
Cost related to financial hardship of co-manufacturer (1) | - | 967 | - | 967 | ||||||||||||||||
Inventory write-downs (2) | - | 465 | - | 465 | ||||||||||||||||
Start-up and idle capacity costs (3) | - | - | - | - | ||||||||||||||||
Costs related to the COVID-19 pandemic (4) | - | - | - | - | ||||||||||||||||
Share-based compensation (5) | - | - | - | - | ||||||||||||||||
Transaction expenses (6) | - | - | (99 | ) | 99 | |||||||||||||||
Adjusted | $ | 9,745 | $ | 1,270 | 13.0 | % | $ | 583 | $ | (1,423 | ) | (14.6 | )% |
(1) Represents costs recognized as a result of a co-manufacturer’s financial hardship. These costs include the non-recurring write down of unrecoverable raw materials inventory.
(2) Represents a non-recurring write-down of obsolete inventory related to a change in strategy for certain products and customers. The amount of the write-down reflects only that portion of obsolete inventory that management estimates to be above normalized levels.
(3) Represents start-up costs associated with commencing operations at our City of Industry Facility and other costs associated with temporary manufacturing capacity at our City of Industry Facility, including indirect labor costs, utility costs, and rent.
(4) Represents direct costs incurred in connection with the COVID-19 pandemic, including freight rush charges, labor costs, tolling upcharges, and storage.
(5) Represents equity-based compensation expense.
(6) Represents costs incurred in connection with pursuing certain strategic and financing transactions, including legal, consulting, and accounting costs.
FAQ
What were Real Good Food's Q3 2021 net sales results?
What is the outlook for Real Good Food in 2022?
What are the adjusted EBITDA losses reported by Real Good Food?
How much did Real Good Food raise in its IPO?